(2017)
Moss-Produced, Glycosylation-Optimized Human Factor H for Therapeutic Application in Complement Disorders.
J Am Soc Nephrol 28(5),
1462-1474.
Publikationen
(2017)
Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator.
J Neuroinflammation 14(1),
4.
(2017)
Vitronectin Binds to a Specific Stretch within the Head Region of Yersinia Adhesin A and Thereby Modulates Yersinia enterocolitica Host Interaction.
J Innate Immun 9(1),
33-51.
(2017)
Immune evasion of Borrelia miyamotoi: CbiA, a novel outer surface protein exhibiting complement binding and inactivating properties.
Sci Rep 7(1),
303.
(2016)
FHR3 Blocks C3d-Mediated Coactivation of Human B Cells.
J Immunol 197(2),
620-629.
(2016)
Complement Factor H-Related 5-Hybrid Proteins Anchor Properdin and Activate Complement at Self-Surfaces.
J Am Soc Nephrol 27(5),
1413-1425.
(2016)
The glycolytic enzyme enolase represents a plasminogen-binding protein on the surface of a wide variety of medically important fungal species.
Int J Med Microbiol 306(1),
59-68.
(2016)
Pseudoxylallemycins A-F, cyclic tetrapeptides with rare allenyl modifications isolated from Pseudoxylaria sp. X802: A competitor of fungus-growing termite cultivars.
Org Lett 18,
3338-3341.
(2016)
Conserved Patterns of Microbial Immune Escape: Pathogenic Microbes of Diverse Origin Target the Human Terminal Complement Inhibitor Vitronectin via a Single Common Motif.
PLOS ONE 11(1),
e0147709.
(2016)
BGA66 and BGA71 facilitate complement resistance of Borrelia bavariensis by inhibiting assembly of the membrane attack complex.
Mol Immunol 99,
407-424.